Trial
NCT06519669
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Grit Biotechnology
Collaborators
—
Condition
Adult
Intervention
GT201 injection
Why stopped
The study was terminated from a business perspective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-27